BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Operating Expenses (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) recorded Operating Expenses of $350.76 million in Q2 2026, up 43.3% from $244.84 million a year earlier and up 16.7% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Operating Expenses (2018 - 2026) Analysis & Trends

On a TTM basis, BridgeBio Pharma's Operating Expenses came in at $1.21 billion as of Jun 30, 2026, up 35.7% year-over-year; for FY2025, it came in at $1.03 billion, up 25.8% from FY2024.

  • Annual Operating Expenses has increased for three straight years, with a five-year compound annual growth rate of 16.3% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $814.88 million in FY2024 (+32.1%), $616.67 million in FY2023 (+4.5%), $589.85 million in FY2022 (-8.7%) and $646.35 million in FY2021 (+33.9%).
  • The Q2 2026 figure is the highest quarterly Operating Expenses in data going back to Q2 2018.
  • On a year-over-year basis, Operating Expenses has increased for 12 consecutive quarters, with growth averaging 29.4% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 64.7% in Q1 2024, against a decline of 27.0% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $300.47 million (Q1 2026), $293.74 million (Q4 2025) and $265.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn 350.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 350.76 Mn
Mar 31, 2026 300.47 Mn
Dec 31, 2025 293.74 Mn
Sep 30, 2025 265.90 Mn
Jun 30, 2025 244.84 Mn
Mar 31, 2025 221.01 Mn
Dec 31, 2024 231.91 Mn
Sep 30, 2024 194.48 Mn
Jun 30, 2024 177.71 Mn
Mar 31, 2024 210.78 Mn
Dec 31, 2023 179.16 Mn
Sep 30, 2023 161.78 Mn
Jun 30, 2023 147.74 Mn
Mar 31, 2023 127.99 Mn
Dec 31, 2022 131.10 Mn
Sep 30, 2022 129.45 Mn
Jun 30, 2022 153.92 Mn
Mar 31, 2022 175.37 Mn
Dec 31, 2021 178.50 Mn
Sep 30, 2021 151.84 Mn
API Access

BridgeBio Pharma Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=BBIO&period=max&api_key=YOUR_API_KEY